BiotechTube
Home/T-Knife Therapeutics/Thomas Soloway
TS

Thomas Soloway

Chief Executive Officer

T-Knife Therapeutics

Therapeutic Areas

Oncology

T-Knife Therapeutics Pipeline

DrugIndicationPhase
TK-6302PRAME-positive solid tumorsPre-clinical

Leadership Team at T-Knife Therapeutics

EK
Elisa Kieback, Ph.D.
Chief Technology Officer & Co-founder
CL
Camille Landis
Chief Business Officer / Chief Financial Officer
PS
Peggy Sotiropoulou, Ph.D.
Chief Scientific Officer
View full T-Knife Therapeutics profile